Literature DB >> 6339098

Unequivocal demonstration that malondialdehyde is a mutagen.

A K Basu, L J Marnett.   

Abstract

Malondialdehyde (MDA), a product of lipid peroxidation and prostaglandin biosynthesis, has been reported to be mutagenic and carcinogenic. Recent evidence suggests, however, that strongly mutagenic impurities are generated during the preparation of MDA that may contribute to the observed biological activity. Since MDA is widely produced in animal tissue it is important to establish whether it is actually mutagenic and carcinogenic. We have utilized three complementary methods for the preparation of highly purified MDA for biological testing. These are chromatographic purification of the sodium salt of MDA, sublimation of the free acid of MDA, and basic hydrolysis of beta-(p-nitrophenoxy)acrolein. The latter is a unique method that we have developed specifically to generate MDA under non-acidic conditions where it is stable. MDA prepared by each method induced approximately 5 revertants/mumol in Salmonella typhimurium his D 3052. This unequivocally demonstrates that MDA is a weak mutagen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339098     DOI: 10.1093/carcin/4.3.331

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  43 in total

Review 1.  Breast tissue composition and susceptibility to breast cancer.

Authors:  Norman F Boyd; Lisa J Martin; Michael Bronskill; Martin J Yaffe; Neb Duric; Salomon Minkin
Journal:  J Natl Cancer Inst       Date:  2010-07-08       Impact factor: 13.506

2.  Site-specific synthesis of oligonucleotides containing malondialdehyde adducts of deoxyguanosine and deoxyadenosine via a postsynthetic modification strategy.

Authors:  Hao Wang; Ivan D Kozekov; Albena Kozekova; Pamela J Tamura; Lawrence J Marnett; Thomas M Harris; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2006-11       Impact factor: 3.739

3.  Gas chromatographic analysis of free and bound malonaldehyde in rat liver homogenates.

Authors:  T Ichinose; M G Miller; T Shibamoto
Journal:  Lipids       Date:  1989-10       Impact factor: 1.880

Review 4.  Oxidative stress--implications, source and its prevention.

Authors:  Rajbir Kaur; Jasmit Kaur; Jyoti Mahajan; Rakesh Kumar; Saroj Arora
Journal:  Environ Sci Pollut Res Int       Date:  2013-10-30       Impact factor: 4.223

5.  Urinary malondialdehyde and 8-hydroxydeoxyguanosine as potential markers of oxidative stress in industrial art glass workers.

Authors:  C Tagesson; M Källberg; G Wingren
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

6.  Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies.

Authors:  Venkatraman Magesh; Jayapal Prince Vijaya Singh; Karupaya Selvendiran; Ganapathy Ekambaram; Dhanapal Sakthisekaran
Journal:  Mol Cell Biochem       Date:  2006-05-10       Impact factor: 3.396

Review 7.  Generation of mutagens during arachidonic acid metabolism.

Authors:  L J Marnett
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

8.  Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde.

Authors:  S P Fink; G R Reddy; L J Marnett
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

9.  Analysis of free malondialdehyde in photoirradiated corn oil and beef fat via a pyrazole derivative.

Authors:  K Umano; K J Dennis; T Shibamoto
Journal:  Lipids       Date:  1988-08       Impact factor: 1.880

10.  Identification of N-epsilon-(2-propenal)lysine as a major urinary metabolite of malondialdehyde.

Authors:  H H Draper; M Hadley; L Lissemore; N M Laing; P D Cole
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.